[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360527-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-360527-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","analysis-of-risk-factors-for-bloodstream-infections-related-to-totally-implantable-venous-access-ports-in-breast-cancer-patients-observational-study","Analysis of risk factors for bloodstream infections related to totally implantable venous access ports in breast cancer patients - observational study","","Catheter-related bloodstream infection (CRBSI) is a significant complication of totally implantable venous access ports (TIVAP) in breast cancer care, increasing cost, delaying therapy, and posing potential life-threatening risk. A retrospective observational analysis reviewed 455 breast cancer patients receiving TIVAP between March 2021 and March 2024. Demographic, treatment-related, and catheter-specific variables were assessed, and univariate and multivariate logistic regression quantified associations. Incidence of CRBSI was 13.63%. Multivariate results showed a recent localized catheter infection within 3 months as the sole independent risk factor (OR=3.86, P\u003C.001).",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/analysis-of-risk-factors-for-bloodstream-infections-related-to-totally-implantable-venous-access-ports-in-breast-cancer-patients-observational-study/360527/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/analysis-of-risk-factors-for-bloodstream-infections-related-to-totally-implantable-venous-access-ports-in-breast-cancer-patients-observational-study/360527.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in breast cancer patients with TIVAP?","Question",{"text":63,"@type":64},"The study addresses catheter-related bloodstream infection (CRBSI) as a significant complication of totally implantable venous access ports used in breast cancer treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the risk analysis conducted in this study?",{"text":68,"@type":64},"It used a retrospective analysis of 455 patients treated with TIVAP from March 2021 to March 2024, followed by univariate and multivariate logistic regression on demographic, treatment-related, and catheter-specific factors.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factor was identified as the sole independent risk factor for CRBSI?",{"text":72,"@type":64},"A history of localized catheter infections within 3 months was the only independent risk factor in multivariate analysis (OR=3.86, P\u003C.001).",{"name":74,"@type":61,"acceptedAnswer":75},"What incidence of CRBSI did the study report?",{"text":76,"@type":64},"Among the 455 patients, the incidence of CRBSI was 13.63%.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},360527,1790545554,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":106,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nAnalysis of risk factors for bloodstream infections related to totally implantable venous access ports in breast cancer patients  \nCongying Chen, MDa , Zhihui Yu, MDa , Qing Lin, MDa , Jie Wang, MDa , Xiaoling Li, MDa , Zhiqiang Wu, MDb , Bingkeng Chen, MDc , Xianglan Lin, MDa , Naying Yu, MDa ,*  \n\n| Abstract\u003Cbr>Catheter-related bloodstream infection (CRBSI) is a significant complication of totally implantable venous access ports (TIVAP) used in breast cancer treatment. This study explores the risk factors for CRBSI in this patient group to inform prevention strategies. A retrospective analysis was conducted on 455 breast cancer patients treated with TIVAP between March 2021 and March 2024. Clinical data, including demographic, treatment-related, and catheter-specific factors, were analyzed. Univariate and multivariate logistic regression identified significant risk factors for CRBSI. Among the 455 patients, the incidence of CRBSI was 13.63% . Univariate analysis revealed significant associations between CRBSI and age, Karnofsky Performance Status at admission, education level, history of localized catheter infections within 3 months, and incisional infections (P \u003C .05) . However, multivariate analysis identified a history of localized catheter infections within 3 months as the sole independent risk factor (OR = 3.86, P \u003C .001) . A history of localized catheter infections within 3 months is an independent risk factor for CRBSI in breast cancer patients with TIVAP. Enhanced infection prevention strategies focusing on high-risk individuals are essential to reduce CRBSI incidence.\u003Cbr>Abbreviations: CRBSI = catheter-related bloodstream infection, KPS = KARNOFSKY performance status, ROC = receiver operating characteristic, TIVAP = totally implantable venous access port. |\n| --- |\n| Keywords: bloodstream infection, breast cancer, risk factor, totally implantable venous access port |\n\n1. Introduction  \nBreast cancer is one of the most common cancers among women globally, accounting for approximately 11.6% of female cancer cases, and its high mortality rate creates a significant health burden worldwide. [1,2] Chemotherapy is one of the main treatments for breast cancer.[3] Totally implantable venous access ports (TIVAP) are the preferred mode of intravenous infusion for breast cancer patients. Compared with peripheral central venous catheters and percutaneous perforated central venous catheters, TIVAP has the advantages of no catheter exposure, a long service life, and no restriction of movement. [4–6] However, catheter-related bloodstream infection (CRBSI) remains a common complication of TIVAP, which is characterized by the development of bacteremia or fungemia, accompanied by fever, chills, or hypotension during  \nthe placement of the catheter or within 48 hours after its removal. [7–9]  \nCRBSI is one of the most serious complications of TIVAP, which not only significantly increases patients’ hospitalization costs and delays treatment, but may even be life-threatening. [10,11] Studies have shown that the incidence of CRBSI in breast cancer patients using TIVAP ranges from 1.44 to 8.6% . [12,13] Currently, it has become a hot research topic to explore the risk factors of CRBSI and develop interventions. It has been suggested that hematoma, history of chemotherapy, and the number of catheterization days per month are strongly associated with the development of CRBSI. [14–16] In addition, elevated C-reactive protein levels, a combination of other procedures, hospitalization setting, and history of prior hematologic malignancies have also been identified as potential risks. [17] Some studies have shown that age ≥ 60 years is an independent risk factor. Another study,  \nCC and XL contributed to this article equally.  \nAll authors contributed significantly to the submitted work, met the authorship criteria and approved this manuscript’s content and submission.  \nThe authors have no funding and conflicts of in","cbCaijs6W0lI6Zks","https://ap.wps.com/l/cbCaijs6W0lI6Zks","pdf",977086,"English","# Introduction\n## CRBSI background and clinical significance\n## TIVAP and current research on risk factors\n# Methods\n## Retrospective study design and patient cohort\n# Results\n## Incidence and univariate risk associations\n## Multivariate logistic regression findings\n# Conclusion\n## Prevention focus for high-risk patients","[{\"question\":\"What problem does the study address in breast cancer patients with TIVAP?\",\"answer\":\"The study addresses catheter-related bloodstream infection (CRBSI) as a significant complication of totally implantable venous access ports used in breast cancer treatment.\"},{\"question\":\"How was the risk analysis conducted in this study?\",\"answer\":\"It used a retrospective analysis of 455 patients treated with TIVAP from March 2021 to March 2024, followed by univariate and multivariate logistic regression on demographic, treatment-related, and catheter-specific factors.\"},{\"question\":\"Which factor was identified as the sole independent risk factor for CRBSI?\",\"answer\":\"A history of localized catheter infections within 3 months was the only independent risk factor in multivariate analysis (OR=3.86, P\\u003c.001).\"},{\"question\":\"What incidence of CRBSI did the study report?\",\"answer\":\"Among the 455 patients, the incidence of CRBSI was 13.63%.\"}]","Analysis of risk factors for bloodstream infections related to totally implantable venous access ports in breast cancer patients - observational study | PDF",1790140403,15,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fa26df5faa1fda10ed1626312b764a9.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b3d9c60d0d16c2f4d8b2c6071e3a19f.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/365bf8ca8edaccb0047385ebee0b0966.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/543ed69d682f53005e1c70e47b85d8e2.webp",980,1306]